Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.
Auteurs : Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P Année : 2020 Journal : Radiol Case Rep
Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.
Auteurs : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P Année : 2020 Journal : Oncotarget
A dosimetry procedure for organs-at-risk in <sup>177</sup>Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.
Auteurs : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Reynaert N, Vandenberghe S, Flamen P Année : 2018 Journal : Phys Med
90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.
Auteurs : Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, Hendlisz A, Vanderlinden B, Flamen P Année : 2018 Journal : EJNMMI Res
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse Event.
Auteurs : Karfis I, Marin G, Machiels G, Hendlisz A, Flamen P Année : 2018 Journal : Clin Nucl Med